Semaglutide coverage for weight loss could cost Medicare billions: study-(It's only Money just print more...)

[Duaine]

If all newly eligible patients received semaglutide, Medicare Part D spending could increase by $34 billion to $145 billion each year, according to new research.

• The analysis found 3.6 million people are highly likely to be eligible for semaglutide like Wegovy, a GLP-1 that’s effective at treating obesity. More liberal definitions of eligibility could increase that number to 15.2 million patients.
• If all newly eligible patients received semaglutide, spending in Medicare’s Part D prescription drug benefit could increase by $34 billion to $145 billion each year, according to the study. Even if the government narrowly defined eligibility, federal spending on the medicine could still exceed $10 billion annually.
• [EXTERNAL LINK] - Semaglutide coverage for weight loss could cost Medicare billions: study

 

[MedicareWAA]

They’ll negotiate the price

 

[goillini52]

Not sure where to put this....It's long, but good.